Clinical Knowledge Graphs For Genomics Market Valued At $3.74 Billion In 2026: Key Trends And Growth Drivers
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Clinical Knowledge Graphs For Genomics Market Growth From $1.76 Billion In 2026 To $3.74 Billion By 2030 At A CAGR Of 20.7%
The clinical knowledge graphs for genomics market has experienced substantial expansion in recent years. This market is projected to increase from $1.46 billion in 2025 to $1.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 20.4%. The historical growth can be linked to several key factors, such as the surge in genomic research initiatives, the implementation of early clinical knowledge graph platforms, an escalating demand for precision medicine, the advancement of bioinformatics tools, and the broadening of clinical research data sets.
The market size for clinical knowledge graphs in genomics is set to experience significant expansion over the next few years. It is projected to grow to $3.74 billion in 2030, achieving a compound annual growth rate (CAGR) of 20.7%. The expansion anticipated during this forecast period stems from factors such as the increasing integration of AI-driven analytics, a greater reliance on cloud-based deployment models, the escalating demand for personalized medicine solutions, the broadening of genomic data annotation services, and a heightened focus on drug discovery applications. Prominent trends within the forecast period include the rising adoption of cloud-based knowledge graph platforms, an increasing need for genomic data integration software, an intensified focus on tools for variant interpretation and annotation, the development of visualization and network analytics solutions, and the expanding implementation of consulting and custom knowledge modeling services.
Get A Free Sample Report With In-Depth Market Insights:
Clinical Knowledge Graphs For Genomics Market Industry Drivers: What’s Behind The Revenue Growth?
The expanding implementation of precision medicine is anticipated to boost the development of clinical knowledge graphs for the genomics market. Precision medicine represents a medical methodology that customizes disease prevention and treatment based on an individual’s genetic composition, environmental factors, and lifestyle choices. Its rising prevalence is propelled by advancements in genomic technologies, a reduction in sequencing expenses, and a heightened emphasis on targeted and individualized therapies. Clinical knowledge graphs facilitate precision medicine by organizing and combining these intricate connections, enabling medical practitioners and researchers to pinpoint personalized treatment pathways, foresee drug responses, and uncover novel therapeutic targets with greater efficacy. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the US food and drug administration granted approval for 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Thus, the increasing embrace of precision medicine is stimulating the expansion of clinical knowledge graphs for the genomics market.
Clinical Knowledge Graphs For Genomics Market Segment Breakdown: Which Categories Lead On Revenue?
The clinical knowledge graphs for genomics market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Drug Discovery, Disease Diagnosis, Personalized Medicine, Clinical Research, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Software: Knowledge Graph Construction Platforms, Genomic Data Integration Software, Ontology And Semantic Mapping Tools, Variant Interpretation And Annotation Software, Visualization And Network Analytics Tools
2) By Services: Implementation And System Integration Services, Data Curation And Annotation Services, Consulting And Custom Knowledge Modeling Services, Maintenance And Technical Support Services, Training And Education Services
#Clinical Knowledge Graphs For Genomics Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies active in the clinical knowledge graphs for the genomics market are concentrating on developing advanced solutions, such as genomic variant interpretation, to facilitate accurate disease diagnosis, customized treatment plans, and accelerated drug discovery. Genomic variant interpretation involves the analysis of individual DNA sequence differences to ascertain their potential implications for health, disease susceptibility, or treatment efficacy, thereby assisting clinicians and researchers in making informed choices within precision medicine. For example, in December 2024, Genomenon Inc., a US-based genomic intelligence company, launched the Genomenon Genomic Graph (G³) knowledgebase, an innovative AI-driven platform that consolidates all clinically relevant empirical genomics evidence into a single searchable graph, powering sophisticated predictive models for clinical diagnostics and drug development. This G³ knowledgebase integrates patient and biological data from nearly every published scientific and medical study, utilizes proprietary curated datasets to train its underlying large language models for greater accuracy, offers natural language search and structured generative AI insights, and enables the discovery of novel clinical and genomic relationships previously hidden within existing literature.
Clinical Knowledge Graphs For Genomics Market Competitive Overview And Top Companies
Major companies operating in the clinical knowledge graphs for genomics market are UnitedHealth Group, Microsoft Corporation, IBM Corporation, Bayer AG, Oracle Corporation, AstraZeneca plc, BC Platforms Ltd., RELX plc, Illumina Inc., Tempus AI Inc., Neo4j Inc., SOPHiA GENETICS SA, Seven Bridges Genomics Inc., DNAnexus Inc., Lifebit Biotech Ltd., Fabric Genomics Inc., PierianDx Inc., Elsevier, Ontotext Corporation, Biorelate Ltd., Ingentium Inc., Genomenon Inc., and Medvolt A.
View The Full Clinical Knowledge Graphs For Genomics Market Report:
Clinical Knowledge Graphs For Genomics Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the clinical knowledge graphs for genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical knowledge graphs for genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
